Literature DB >> 3464210

Pharmacotherapeutics in fibrositis.

R A Gatter.   

Abstract

Fibrositis (fibromyalgia) is best treated by attaining patient acceptance of and compliance with a comprehensive treatment program. This includes education, physical therapy, muscle and mental relaxation, examination and adjustment of goals and priorities, and pacing of activities, as well as pharmacotherapeutics. Of the medications in use, anti-inflammatory agents with a high degree of analgesia are more effective than "pure" anti-inflammatory agents. Tricyclic derivatives are beneficial muscle relaxants. The use of long-acting agents improves compliance and is therefore favored. Local agents are of adjunctive value in some cases. Double-blind, placebo-controlled studies show cyclobenzaprine to be an effective medication in the treatment of fibrositis (fibromyalgia).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3464210     DOI: 10.1016/0002-9343(86)90878-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  2 in total

1.  Treatment of fibromyalgia (fibrositis syndrome): a parallel double blind trial with carisoprodol, paracetamol and caffeine (Somadril comp) versus placebo.

Authors:  H Vaerøy; A Abrahamsen; O Førre; E Kåss
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

Review 2.  Fibrositis (fibromyalgia). A common non-entity?

Authors:  F D Hart
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.